NCI-H460 폐암 유발 누드마우스 모형을 이용한 난담반의 항암 효과 연구
Anticancer Effects of Egg White Combined-Chalcanthite on NCI-H460 Tumor Regression Model
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
This experimental study was performed to investigate the antitumor effect of Egg white combined-Chalcanthite (InSan 4, IS4) in xenografted nude mice with NCI-H460 human lung cancer cell. We cultured NCI-H460 cell lines and xenografted them on nude mice. These mice were divided into 3 groups; group with dose of 45 ㎎/㎏ IS4 orally, group with dose of 90 ㎎/㎏ IS4 orally, and the control group. They had been raised and treated for 28 days. We checked their body weight, tumor weight and volume twice a week, and their absolute organ weight, microhistological observation and biochemical blood analysis at the final day by sacrificing them. We also calculated their tumor inhibition rate (IR), mean survival time and percent increase in life span (% ILS). In this study, we observed that all of the IS4 treated mice have tumor regression, dosage-dependently, compared to the control group. Tumor weight and volume of high dose treated mice were smallest. IR increased in IS4 in a dose-dependent manner. Mean survival time and percent increase in life span (% ILS) in high-dose IS4 treatment group were the highest of the three groups. There was no significant difference in biochemical blood analysis, alanine phopsphatase (ALP), Calcium, creatinine (CRE), alanine transferase (ALT), and aspartate transaminase (AST) levels. The urea nitrogen (UN) level results significantly decreased by IS4 45 and 90 ㎎/㎏ (IS4 45 mg/kg, IS4 90 mg/kg, p<0.01). IS4 may have potential anti-tumor effect in a solid tumor induced by NCI-H460 without remarkable side effects.
Abstract
This experimental study was performed to investigate the antitumor effect of Egg white combined-Chalcanthite (InSan 4, IS4) in xenografted nude mice with NCI-H460 human lung cancer cell. We cultured NCI-H460 cell lines and xenografted them on nude mice. These mice were divided into 3 groups; group with dose of 45 ㎎/㎏ IS4 orally, group with dose of 90 ㎎/㎏ IS4 orally, and the control group. They had been raised and treated for 28 days. We checked their body weight, tumor weight and volume twice a week, and their absolute organ weight, microhistological observation and biochemical blood analysis at the final day by sacrificing them. We also calculated their tumor inhibition rate (IR), mean survival time and percent increase in life span (% ILS). In this study, we observed that all of the IS4 treated mice have tumor regression, dosage-dependently, compared to the control group. Tumor weight and volume of high dose treated mice were smallest. IR increased in IS4 in a dose-dependent manner. Mean survival time and percent increase in life span (% ILS) in high-dose IS4 treatment group were the highest of the three groups. There was no significant difference in biochemical blood analysis, alanine phopsphatase (ALP), Calcium, creatinine (CRE), alanine transferase (ALT), and aspartate transaminase (AST) levels. The urea nitrogen (UN) level results significantly decreased by IS4 45 and 90 ㎎/㎏ (IS4 45 mg/kg, IS4 90 mg/kg, p<0.01). IS4 may have potential anti-tumor effect in a solid tumor induced by NCI-H460 without remarkable side effects.
참고문헌 (32)
- 김원재, "경구용 항암제", 대한의사협회지, 50(5), pp.464~470 (2007)
- Kasper Braunwald, "Harrison’s 내과학", pp.501~536 (2006), 도서출판 MIP
- Park, S.C, "Recent Experimental Tendency for Herbal Medicines Treating Lung Cancer in South Korea", Journal of Korean Traditional Oncology, 13(1), pp.43~54 (2008)
- 具滋權, "平消丹加減方의 抗癌性에 關한 實驗的 硏究", 동의병리학회지, 11(1), pp.49~57 (1997)
- 박승찬, "Akt 활성억제 및 Caspase-3의 활성화를 통한 삼칠근 열수 추출물의 인간 폐암세포에서의 세포사멸 유도", 박사, pp.2009
- 박상은, "인체 폐암세포에서 동충하초 추출물의 세포사멸 유도 및 telomerase 활동 억제", 박사, pp.2009
- 홍문화, "한국의 광물성 한약(1)", 생약학회지, 4(3), pp.105~152 (1973)
- 허 성, "정신질환에 사용된 광물성 약재에 대한 고찰", 동의신경정신과학회지, 10(1), pp.159~177 (1999)
- 한현정, "홍삼의 법제유황 처리가 당뇨쥐의 혈중지질 및 대사지표물질에 미치는 영향", 대한본초학회지, 24(1), pp.89~98 (2009), 대한본초학회
- 徐富一, "鑛物藥의 利用 現況에 관한 調査", 東西醫學, 23(3), pp.1~5 (1998)
- 吳普, "神農本草經", pp.27~ (2003), 의성당
- 이장천, "동의약용광물학", pp.57~ (2005), 의성당
- 仁山 金一勳, "宇宙와 神藥", pp.145~ (1980), 동문출판사
- 仁山 金一勳, "救世神方", pp.155~ (1981), 제일사
- 仁山 金一勳, "神藥", pp.47~ (1986), 나무출판사
- 최은아, "난담반의 인체폐암세포주 NCI-H460에 대한 세포자살유도 효능", 대한약침학회지, 12(3), pp.49~60 (2009), 대한약침학회
- Teicher, B.A, "Anticancer Drug Development Guide", pp.91~97 (1997), Humana Press
- Langdon, S.P, "Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study", Ann Oncol, 5(5), pp.415~422 (1994)
- 李梃, "醫學入門", pp.162~163 (1989), 고려의학
- 李時珍, "本草綱目", pp.350~351 (1982), 文光圖書有限公司
- 최은아, "난담반의 인체폐암세포주 NCI-H460에 대한 세포자살유도 효능", 석사, 보건학, pp.2009
- 허 준, "東醫寶鑑", pp.748~ (1989), 南山堂
- 강병수, "本草學", pp.637~ (1991), 圖書出版 永林社
- 김창민, "中藥大事典", pp.786~ (1999), 도서출판 정담
- 최진호, "가축영양에서의 유황", 유황비료 국제심포지움, pp.101~ (1988), 한국토양비료학회
- 최보영, "청소년기 여자에서 고칼슘 섭취가 아연과 구리 평형에 미치는 영향", 한국식품영양과학회지, 30(5), pp.894~899 (2001)
- 최재혁, "체내 철 수준이 뇌로의 구리 이동과 분포에 미치는 영향", 한국독성학회지, 23(3), pp.279~287 (2007), 한국독성학회
- 이명수, "류마티스 관절염 환자의 혈중 아연 및 구리 농도와 질병 활성도와의 관계", 대한류마티스학회지, 10(4), pp.9~422 (2003), 대한류마티스학회
- 한국식품개발연구원, "Phosvitin과 Lysozyme의 기능성 식품 소재화 연구", pp.90~92 (2002), 농림부
- 박봉규, "길경 수용액 추출물에 의한 NCI-H460 인체 폐암세포의 p53 및 pRB의 발현에 미치는 영향", 동의생리병리학회지, 20(6), pp.1530~1537 (2006), 대한동의병리학회
- 김진영, "A539 및 NCI-H460 인체 폐암세포의 증식 및 apoptosis 유도에 미치는 가미삼기보폐탕의 영향", 대한한방내과학회지, 29(1), pp.130~148 (2008), 대한한방내과학회
- 허만규, "인체폐암세포 NCI-H460 및 A549의 증식에 미치는 參？補肺湯의 영향 비교", 동의생리병리학회지, 21(4), pp.973~981 (2007), 대한동의병리학회